Ledger.Open graph →
SEC Form D · Amendment · filed September 9, 2025

Reunion Neuroscience, Inc

Offering
$119.8M
Sold
$119.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MORRISTOWN, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Nathan Bryson · Morristown, NJExecAlon Lazarus · Morristown, NJDirectorMark Theeuwes · Morristown, NJExecNatalie Sacks · Morristown, NJDirectorAnsbert Gadicke · Morristown, NJDirectorMark Pollack · Morristown, NJExecGregory Mayes · Morristown, NJExec · DirectorEdward Smith · Morristown, NJExecMichael Ehlers · Morristown, NJDirectorEllen Lubman · Morristown, NJDirectorMark Pollack · Morristown, NJExecNatalie Sacks · Morristown, NJDirectorAlon Lazarus · Morristown, NJDirectorMark Theeuwes · Morristown, NJExecAnsbert Gadicke · Morristown, NJDirectorMichael Ehlers · Morristown, NJDirectorGregory Mayes · Morristown, NJExec · DirectorEllen Lubman · Morristown, NJDirectorNathan Bryson · Morristown, NJExecEdward Smith · Morristown, NJExecMary J. Haak-Frendscho, Ph.D · South San Francisco, CAExec · DirectorTim J. Kutzkey, Ph.D · South San Francisco, CAExecShao-Lee J. Lin, M.D., Ph.D · South San Francisco, CADirectorGregory Mckinley · Minneapolis, MNDirectorVenkateswara R. Gottipatti · FRISCO, TXExecKathleen Wood · Shorewood, WIExecSteven Bruce · Shorewood, WIDirectorLasse Clausen · GRAND CAYMAN, Cayman IslandsDirectorZehan Lai · Singapore, U0ExecSergey I. Knysh · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗